Advertisements
Ganly, Ian

Ganly, Ian

Memorial Sloan-Kettering Cancer Center, United States

2024 Rank: 111,754

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Otorhinolaryngology

Rank in SubField 1: 4,303 out of 334,837 Researchers

Data For The Year: 2024
Metrics Self-Citations Excluded All
Rank Based on Composite Score111,754120,844
Total Cites18,19220,193
H-index6671
Hm-index2021
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers4747
Total Cites to Single+First Authored Papers2,8953,172
Number of Single+First+Last Authored Papers151151
Total Cites to Single+First+Last Authored Papers5,9916,498
Composite Score33
Number of Distinct Citing Papers14,47515,527
Ratio of Total Citations to Distinct Citing Papers 1.26 1.30
Self-Citation Percentage
9.91%
Found an error in your data? Contact us with your profile link. Contact Us →
Ganly, Ian

Ganly, Ian

Memorial Sloan-Kettering Cancer Center, United States

2023 Rank: 117,719

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Otorhinolaryngology

Rank in SubField 1: 4,572 out of 312,644 Researchers

Data For The Year: 2023
Metrics Self-Citations Excluded All
Rank Based on Composite Score117,719126,900
Total Cites15,65817,446
H-index6166
Hm-index1920
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers4444
Total Cites to Single+First Authored Papers2,6602,915
Number of Single+First+Last Authored Papers143143
Total Cites to Single+First+Last Authored Papers5,2925,754
Composite Score33
Number of Distinct Citing Papers12,46613,426
Ratio of Total Citations to Distinct Citing Papers 1.26 1.30
Self-Citation Percentage
10.25%
Found an error in your data? Contact us with your profile link. Contact Us →
Ganly, Ian

Ganly, Ian

Memorial Sloan-Kettering Cancer Center, United States

2022 Rank: 127,347

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Otorhinolaryngology

Rank in SubField 1: 4,882 out of 293,195 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score127,347136,645
Total Cites12,83014,273
H-index5558
Hm-index1718
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers4242
Total Cites to Single+First Authored Papers2,3932,616
Number of Single+First+Last Authored Papers126126
Total Cites to Single+First+Last Authored Papers4,5224,926
Composite Score33
Number of Distinct Citing Papers10,24811,031
Ratio of Total Citations to Distinct Citing Papers 1.25 1.29
Self-Citation Percentage
10.11%
Found an error in your data? Contact us with your profile link. Contact Us →
Ganly, Ian

Ganly, Ian

Memorial Sloan-Kettering Cancer Center, United States

2021 Rank: 127,019

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Otorhinolaryngology

Rank in SubField 1: 4,900 out of 271,773 Researchers

Data For The Year: 2021
Metrics Self-Citations Excluded All
Rank Based on Composite Score127,019137,513
Total Cites11,54012,829
H-index5356
Hm-index1717
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers4141
Total Cites to Single+First Authored Papers2,2932,506
Number of Single+First+Last Authored Papers118118
Total Cites to Single+First+Last Authored Papers4,2744,658
Composite Score33
Number of Distinct Citing Papers9,2119,899
Ratio of Total Citations to Distinct Citing Papers 1.25 1.30
Self-Citation Percentage
10.05%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements